Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study

J Am Acad Dermatol. 2018 Apr;78(4):793-795. doi: 10.1016/j.jaad.2017.10.010. Epub 2017 Oct 14.

¹ University of South Florida, Tampa, Florida.
² The Clinical Research Center of Southern Illinois, Shiloh, Illinois; Washington University School of Medicine, St. Louis, Missouri.
³ Bernstein Clinical Research Center, Cincinnati, Ohio; University of Cincinnati, Cincinnati, Ohio.
⁴ Genentech, Inc, South San Francisco, California.
⁵ Genentech, Inc, South San Francisco, California. Electronic address: holden.michael@gene.com.
⁶ Charleston ENT and Allergy, Charleston, South Carolina.
⁷ Institute for Asthma & Allergy, Chevy Chase, Maryland.
⁸ University of California Los Angeles School of Medicine, Los Angeles, California.
⁹ Medical University of South Carolina, Charleston, South Carolina.

No abstract available

Publication types